Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension
Sign Up to like & getrecommendations! Published in 2020 at "Chest"
DOI: 10.1016/j.chest.2020.08.2069
Abstract: Background Achievement of low-risk status is a treatment goal in pulmonary arterial hypertension (PAH). Risk assessment is often performed using multiparameter tools, such as the Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL)… read more here.
Keywords: risk; reveal risk; reveal lite; reveal ... See more keywords
Application of the REVEAL risk score calculator 2.0 in the CHEST study.
Sign Up to like & getrecommendations! Published in 2022 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2022.106783
Abstract: BACKGROUND Currently there are no risk assessment recommendations for chronic thromboembolic pulmonary hypertension (CTEPH). The Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) risk score (RRS), developed for risk assessment in patients with… read more here.
Keywords: risk; reveal risk; risk score; chest study ... See more keywords
Already high tobacco taxes are still a burden on low-income households
Sign Up to like & getrecommendations! Published in 2020 at "Tobacco Control"
DOI: 10.1136/tobaccocontrol-2020-055734
Abstract: The French Pulmonary Hypertension Network (FPHN) registry and the Registry to Evaluate Early And Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL) have developed predictive models for survival in pulmonary arterial hypertension (PAH). In this collaboration,… read more here.
Keywords: tobacco; reveal risk; high tobacco; already high ... See more keywords